| PERIOD ENDING | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | 30-Jun-07 | | Total Revenue | 3,249,000 | 3,371,000 | 3,165,000 | 2,739,000 | | Cost of Revenue | 1,523,000 | 644,000 | 638,000 | 505,000 | | | Gross Profit | 1,726,000 | 2,727,000 | 2,527,000 | 2,234,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 192,000 | 1,975,000 | 1,689,000 | 1,358,000 | | Non Recurring | 35,000 | 192,000 | 6,000 |
-
| | Others | 33,000 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,466,000 | 560,000 | 832,000 | 876,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,466,000 | 560,000 | 832,000 | 876,000 | | Interest Expense | 663,000 | 254,000 | 281,000 | 313,000 | | Income Before Tax | 803,000 | 306,000 | 551,000 | 563,000 | | Income Tax Expense | 273,000 | 83,000 | 193,000 | 197,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 530,000 | 223,000 | 358,000 | 366,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 530,000 | 223,000 | 358,000 | 366,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $530,000 | $223,000 | $358,000 | $366,000 |
|
0.65% Nasdaq 
0.27%
Income Statement
